November 3, 2021 - Curetalks

Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma.…

Nov 03, 2021, 12:00 pm 0 Listen